en

PRODUCT DETAIL

Imatinib STADA 100 mg tvrdé kapsuly

Code 1423C
MA number 44/0464/16-S
Product Form: cps dur 180x100 mg (blis.Al/PVC/Aclar)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA01 Imatinib
Shelf life: 24
Container: blister Al/PVC/Aclar
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 21.10.2016
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Imatinib STADA 100 mg tvrdé kapsuly_08.2023.pdf  
PIL: PIL_Imatinib STADA 100 mg tvrdé kapsuly_08.2023.pdf  
Safety feature Yes
Data update: 27.10.2021
eu-flag.png sk-flag.png